NEW YORK (GenomeWeb) – It's been a long and winding road for Fluoresentric's proprietary DNA amplification technology, but the firm is hoping that road will lead to the potentially lucrative point-of-care diagnostics market.

The Park City, Utah-based firm said this week that it is launching a new subsidiary to make portable hand-held instruments to run infectious disease assays based on its proprietary chemistry in pharmacies, retail clinics, warehouses, and anyplace where molecular diagnostics has yet to find widespread use.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.